Halozyme Therapeutics, Inc.
HALO
$74.93
$1.532.08%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.62% | 61.38% | 77.40% | 37.87% | 51.90% |
Total Receivables | 47.46% | 55.50% | 31.70% | 31.48% | -12.86% |
Inventory | 13.93% | -2.18% | 11.17% | 1.93% | 20.32% |
Prepaid Expenses | -9.75% | -2.35% | -19.88% | -12.05% | 118.42% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 13.65% | 44.47% | 45.41% | 28.21% | 29.00% |
|
|||||
Total Current Assets | 13.65% | 44.47% | 45.41% | 28.21% | 29.00% |
Net Property, Plant & Equipment | -4.64% | -6.73% | 0.12% | -0.24% | 0.59% |
Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Intangibles | -16.24% | -15.61% | -15.02% | -14.48% | -14.41% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 45.92% | 239.00% | 280.38% | 154.25% | 23.97% |
Total Assets | 4.29% | 19.28% | 19.05% | 11.91% | 8.78% |
|
|||||
Total Accounts Payable | 21.13% | 50.65% | -13.26% | -35.82% | 52.47% |
Total Accrued Expenses | 152.08% | 121.84% | 20.98% | 162.17% | -16.50% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -94.23% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 47.86% |
Total Other Current Liabilities | -- | -- | -- | -- | 47.86% |
Total Current Liabilities | 0.69% | 14.24% | 23.65% | -5.53% | 14.58% |
|
|||||
Total Current Liabilities | 0.69% | 14.24% | 23.65% | -5.53% | 14.58% |
Long-Term Debt | 0.44% | 0.44% | 0.44% | 0.44% | 0.44% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -5.04% | -5.81% | -26.54% | 8.21% | -1.19% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 257.58% | -- | 463.19% | 858.85% | -15.45% |
Total Liabilities | 2.45% | 3.04% | 3.04% | 1.33% | 1.24% |
|
|||||
Common Stock & APIC | -99.62% | -35.25% | -95.15% | 141.59% | 153.07% |
Retained Earnings | 38.53% | 185.57% | 297.43% | 78.88% | 85.56% |
Treasury Stock & Other | -1,273.45% | -129.68% | 141.27% | -665.53% | -28.05% |
Total Common Equity | 14.97% | 171.23% | 334.11% | 81.68% | 91.63% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 14.97% | 171.23% | 334.11% | 81.68% | 91.63% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 14.97% | 171.23% | 334.11% | 81.68% | 91.63% |
|